Xylyx Bio
PrivateLast Round
Grant
Apr 2, 2025
Total Funding Raised
$8.04M
Company Overview
Xylyx Bio is a biotechnology company that develops regenerative biomaterials and biosystems for tissue and organ modeling, repair, and regeneration.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Advanced Materials, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xylyx Bio Comps
Public and private peers based on sector, stage, and business model.
Xylyx Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 2, 2025 | ||||
| Grant | Sep 16, 2024 | ||||
| Grant | Jun 14, 2024 | ||||
| Grant | Sep 2, 2021 |
Key People
Founding team and executive leadership
Xylyx Bio Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
Monthly visitors increased 53% MoM.
- May 3, 2025
Monthly visitors grew 36% MoM, reaching 1.5K.
Xylyx Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Xylyx Bio's valuation, stock price, and market status.
